Programmed cell death 1 checkpoint inhibitors in the treatment of patients with advanced melanoma by Jacek Mackiewicz, Andrzej Mackiewicz

Subjects: Get full text

The comparison of efficacy and safety between cadonilimab (PD-1/CTLA-4) and anti-PD-1 inhibitors in patients with recurrent or metastatic cervical cancer: a retrospective real-worl... by Baoyue Pan, He Huang, Ting Wan, Qidan Huang, Shanyang He, Shijie Xu, Siyu Chen, Jiaxin Yin, Jundong Li, Min Zheng

Subjects: Get full text

Relative expression orderings based prediction of treatment response to Anti-PD-1 immunotherapy in advanced melanoma by Yaru Gao, Yue Huo, Lingli Wang, Jiayi Ruan, Lanzhen Chen, Hongdong Li, Guini Hong

Subjects: Get full text

Real‐Life Cohort of Patients With Resected High‐Risk Melanoma Treated by Adjuvant Anti‐PD1 Therapy by Liza Benzoni, Anaïs Eberhardt, Sarah Milley, Safa Idoudi, Camille Trefcon, Nicolas Romain‐Scelle, Luc Thomas, Stéphane Dalle

Subjects: Get full text

Preclinical Characterization of Efficacy and Pharmacodynamic Properties of Finotonlimab, a Humanized Anti-PD-1 Monoclonal Antibody by Yunqi Yao, Xiaoning Yang, Jing Li, Erhong Guo, Huiyu Wang, Chunyun Sun, Zhangyong Hong, Xiao Zhang, Jilei Jia, Rui Wang, Juan Ma, Yaqi Dai, Mingjing Deng, Chulin Yu, Lingling Sun, Liangzhi Xie

Subjects: Get full text

Risk factors for pneumonitis in patients treated with anti‐programmed death‐1 therapy: A case‐control study by Pengfei Cui, Zhefeng Liu, Guoqiang Wang, Junxun Ma, Yuanyu Qian, Fan Zhang, Chun Han, Yaping Long, Ye Li, Xuan Zheng, Danyang Sun, Jing Zhang, Shangli Cai, Shunchang Jiao, Yi Hu

Subjects: “…anti‐PD‐1…”
Get full text

Circulating immune landscape in melanoma patients undergoing anti-PD1 therapy reveals key immune features according to clinical response to treatment by Eleonora Sosa Cuevas, Eleonora Sosa Cuevas, Stéphane Mouret, Guillaume Vayssière, Guillaume Vayssière, Siham Kerboua, Siham Kerboua, Pauline Girard, Pauline Girard, Jean-Paul Molens, Jean-Paul Molens, Marc Manceau, Julie Charles, Philippe Saas, Philippe Saas, Caroline Aspord, Caroline Aspord

Subjects: Get full text

Lichen Planus-Like Exanthema Induced by Anti-PD-1 and Anti-LAG-3 Combination Immunotherapy Could Potentially Predict the Treatment Response in Metastatic Melanoma by Marek Pasek, Eva Sticová, Emanuel Marques, Vojtěch Tretera, Petr Arenberger, Monika Arenbergerová

Subjects: “…melanoma, anti-PD-1, anti-LAG-3, adverse events…”
Get full text

Insights into the mechanisms of serplulimab: a distinctive anti-PD-1 monoclonal antibody, in combination with a TIGIT or LAG3 inhibitor in preclinical tumor immunotherapy studies by Yizhou Zhang, Ruicheng Wei, Ge Song, Xinyi Yang, Mengli Zhang, Wei Liu, Aiying Xiong, Xuehan Zhang, Qianhao Li, Wan-Jen Yang, Chencheng Han, Rui Liu, Chen Hu, Qingyu Wang, Jun Zhu, Yongqiang Shan

Subjects: “…Anti-PD-1/PD-L1…”
Get full text

Taurine-mediated metabolic immune crosstalk indicates and promotes immunosuppression with anti-PD-1 resistance in bladder cancer by Zhengfang Liang, Fengwei Nong, Fengwei Nong, Zhenjie Li, Runmin Chen, Haoxu Zhao, Yongping Huang, Yongping Huang

Subjects: Get full text

Nivolumab for relapsed and refractory classical Hodgkin lymphoma: retrospective single center analysis by Magdalena Witkowska, Mikołaj Malicki, Weronika Marcinkowska, Kacper Kościelny, Adrianna Kowalik, Damian Mikulski, Grzegorz Mirocha

Subjects: Get full text

Exploring correlations between gut mycobiome and lymphocytes in melanoma patients undergoing anti-PD-1 therapy by Natalia Szóstak, Michał Budnik, Katarzyna Tomela, Luiza Handschuh, Anna Samelak-Czajka, Bernadeta Pietrzak, Marcin Schmidt, Mariusz Kaczmarek, Łukasz Galus, Jacek Mackiewicz, Andrzej Mackiewicz, Piotr Kozlowski, Anna Philips

Subjects: Get full text

Combination of potassium oxonate with anti-PD-1 for the treatment of colorectal cancer by Yuanyuan Wang, Chenxi Hu, Tianpeng Du, Jiawen Li, Kaiyuan Hui, Xiaodong Jiang

Subjects: “…anti-PD-1…”
Get full text

Anti-PD1-/PDL1-induced chronic intestinal pseudo-obstruction: three cases treated with vedolizumab after corticosteroid failure with mixed results by Morgan Zenatri, Michael Collins, Tifanie Alberto, Antonio Farina, Sophie Collardeau-Frachon, Mélanie Saint-Jean, François Bocquet, Frederic Dumont, Jérôme Honnorat, Bastien Joubert, Judith Raimbourg

Subjects: Get full text

Anlotinib combined with penpulimab in the treatment of advanced adult thoracic spinal osteosarcoma: a case report by Xiaochun Chen, Xianqin Li, Haiying Zhao, Jinwen Qu, Xiaojuan Li, Chuan Lin, Zhiping Yuan

Subjects: Get full text

Reversing VTN deficiency inhibits the progression of pancreatic cancer and enhances sensitivity to anti-PD1 immunotherapy by Siqi Zhao, Zhaofeng Gao, Lingyu Hu, Yihan Li, Xiaoguang Wang, Xiaoping Li, Minjie Chen, Fei Chen, Zhengwei Song

Subjects: Get full text

Immune biomarkers in circulating cells of NSCLC patients can effectively evaluate the efficacy of chemotherapy combined with anti-PD-1 therapy by Jing Cao, Yuehua Zhang, Shenghu Guo, Zheng Wu, Xiaojin Guo, Rongze Zhang, Lei Zhang, Ya Liu, Xing Li, Chunwang Yang, Dongwei He, Lu Bai, Tingting Lv, Yong Xie, Chengjing Huang, Shuang Xiao, Anyi Deng, Jiawei Li, Jiawei Li, Jiaxing Zhu, Zhenghu Jia, Zhenghu Jia, Zhinan Yin, Zhiyu Wang

Subjects: Get full text

Alternative Dosing Regimens of Tislelizumab Using a Pharmacometrics Model‐Based Approach by Ahsan Rizwan, Hugh Giovinazzo, Tian Yu, Yuying Gao, Kun Wang, Fengyan Xu, Ya Wan, Jun Wang, Srikumar Sahasranaman, Marcia Campbell, Patrick Schnell, Ramil Abdrashitov, William D. Hanley, Nageshwar Budha

Subjects: Get full text

NIVO-TIL: combination anti-PD-1 therapy and adoptive T-cell transfer in untreated metastatic melanoma: an exploratory open-label phase I trial by Jean-Matthieu L'Orphelin, Ugo Lancien, Jean-Michel Nguyen, Francisco J.S. Coronilla, Soraya Saiagh, Julie Cassecuel, Lise Boussemart, Anne Dompmartin, Brigitte Dréno

Subjects: Get full text

Dedifferentiated liposarcomas treated with immune checkpoint blockade: the MD Anderson experience by Madeline B. Torres, Madeline B. Torres, Cheuk Hong Leung, Marianne Zoghbi, Rossana Lazcano, Davis Ingram, Khalida Wani, Emily Z. Keung, M. Alejandra Zarzour, Christopher P. Scally, Kelly K. Hunt, Anthony Conley, Andrew J. Bishop, B. Ashleigh Guadagnolo, Ahsan Farooqi, Devarati Mitra, Alison K. Yoder, Michael S. Nakazawa, Dejka Araujo, Andrew Livingston, Ravin Ratan, Shreyaskumar Patel, Vinod Ravi, Alexander J. Lazar, Alexander J. Lazar, Christina L. Roland, Neeta Somaiah, Elise F. Nassif Haddad, Elise F. Nassif Haddad

Subjects: Get full text